局部化疗在眼部附性油脂性癌症的有效性
Andrew J Rong1, Matthew Camacho, Sander R Dubovy
1Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida, U.S.A.
Ophthalmic plastic and reconstructive surgery
|September 9, 2025
概括
局部化疗对眼部附性脂质癌 (OaSC) 具有内扩散的局部化疗表现出有限的成功,80%的患者无法实现充分的疾病控制. 线粒素C (MMC) 的分辨率仅为20%,这凸显了需要进一步研究的必要性.
科学领域:
- 眼科医生 眼科 眼科
- 在瘤学瘤学.
- 皮肤病学 皮肤病学
背景情况:
- 眼部副脂癌 (OaSC) 是一种罕见的恶性瘤.
- 皮质内页状腺扩散是一个独特的治疗挑战.
- 需要有效的OaSC与广泛的内皮层参与的管理策略.
研究的目的:
- 评估用于眼部附性脂质癌 (OaSC) 的局部化疗的临床结果.
- 评估局部药物的疗效和不良影响,如米托米辛C (MMC),5-甲和干扰素α-2a.
- 为了确定局部化疗在管理OaSC的潜在作用与页形状的参与.
主要方法:
- 在2000年至2023年期间接受治疗的OaSC患者的回顾性图表审查.
- 纳入标准:经过活检证明的OaSC,内皮质页状体干扰,局部化疗使用,并重复结膜活检.
- 对局部化疗剂的治疗反应,疾病控制和不良事件的分析.
主要成果:
- 在120名OaSC患者中,只有10人符合局部化疗分析的纳入标准.
- 在80%的病例中观察到不充分的内皮层疾病控制.
- 20%的患者通过米托米辛C (MMC) 单一治疗实现了缓解;70%的患者经历了不良反应.
结论:
- 局部化疗在很大程度上是无效的控制眼部附脂性癌症 (OaSC) 页状内皮扩散.
- 线粒素C (MMC) 可能具有作为新辅助疗法的作用,但最佳剂量和持续时间需要进一步调查.
- 显著的不良影响和眼表面共患症需要在OaSC管理中仔细考虑局部化疗.
相关概念视频
01:30Skin Cancer
5.7K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
5.7K
02:49Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K